Legacy Advisors, LLC Eli Lilly & CO Transaction History

Legacy Advisors, LLC

$918 Million
Q3 2024

A detailed history of Legacy Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Legacy Advisors, LLC holds 7,681 shares of LLY stock, worth $6.64 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares

7,681

Previous 7,138 7.61%

Holding current value

$6.64 Million

Previous $6.46 Million 5.29%

% of portfolio

0.74%

Previous 0.79%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$772.14 - $960.02 $419,272 - $521,290	543 Added 7.61%	7,681 $6.8 Million
Q2 2024 Jul 30, 2024	BUY	$724.87 - $909.04 $600,917 - $753,594	829 Added 13.14%	7,138 $6.46 Million
Q1 2024 Apr 30, 2024	BUY	$592.2 - $792.28 $862,835 - $1.15 Million	1,457 Added 30.03%	6,309 $4.91 Million
Q4 2023 Feb 12, 2024	BUY	$525.19 - $619.13 $1.47 Million - $1.74 Million	2,807 Added 137.26%	4,852 $2.83 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $113,891 - $157,016	262 Added 14.69%	2,045 $1.1 Million
Q2 2023 Jul 20, 2023	BUY	$350.74 - $468.98 $43,842 - $58,622	125 Added 7.54%	1,783 $836,000
Q1 2023 May 01, 2023	BUY	$310.63 - $364.82 $13,667 - $16,052	44 Added 2.73%	1,658 $569,000
Q4 2022 Feb 01, 2023	BUY	$321.55 - $374.67 $27,653 - $32,221	86 Added 5.63%	1,614 $590,000
Q3 2022 Nov 09, 2022	SELL	$296.48 - $337.87 $117,702 - $134,134	-397 Reduced 20.62%	1,528 $494,000
Q2 2022 Jul 25, 2022	BUY	$278.73 - $327.27 $124,313 - $145,962	446 Added 30.16%	1,925 $624,000
Q1 2022 May 11, 2022	BUY	$234.69 - $291.66 $145,038 - $180,245	618 Added 71.78%	1,479 $424,000
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $193,595 - $240,253	861 New	861 $238,000
Q3 2019 Oct 10, 2019	SELL	$106.79 - $116.16 $156,554 - $170,290	-1,466 Closed	0 $0
Q2 2019 Jul 15, 2019	BUY	$110.79 - $129.32 $68,689 - $80,178	620 Added 73.29%	1,466 $162,000
Q1 2019 Apr 08, 2019	BUY	$111.31 - $131.02 $94,168 - $110,842	846 New	846 $110,000
Q4 2018 Jan 14, 2019	SELL	$105.9 - $118.64 $89,485 - $100,250	-845 Closed	0 $0
Q3 2018 Oct 18, 2018	SELL	$85.86 - $107.31 $43,702 - $54,620	-509 Reduced 37.59%	845 $91,000
Q2 2018 Jul 19, 2018	BUY	$75.7 - $86.88 $55,488 - $63,683	733 Added 118.04%	1,354 $116,000
Q1 2018 Apr 17, 2018	BUY	$74.21 - $87.6 $20,110 - $23,739	271 Added 77.43%	621 $49,000
Q4 2017 Jan 26, 2018	BUY	$81.94 - $87.89 $12,372 - $13,271	151 Added 75.88%	350 $29,000
Q3 2017 Nov 03, 2017	BUY	$77.07 - $85.54 $3,776 - $4,191	49 Added 32.67%	199 $17,000
Q4 2016 Nov 03, 2017	BUY	N/A	150	150 $11,000

Others Institutions Holding LLY

# of Institutions

4,139

Shares Held

743M

Call Options Held

8.35M

Put Options Held

10.2M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $822B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Legacy Advisors, LLC with notifications on news.

Account

Legacy Advisors, LLC Eli Lilly & CO Transaction History